You are here

ACE910

Roche’s hemophilia drug slashes bleeding rate, boosting blockbuster projections — but doubts on safety linger

Endpoints

Mon, 06/26/17 - 09:54 am

clinical trials

Roche confirms patient death in ACE910 PhIII hemophilia trial, spurring new questions about top blockbuster hopeful

Endpoints

Fri, 02/24/17 - 11:39 am

clinical trials

Roche readies a hunt for marketing OK on hemophilia blockbuster hopeful emicizumab after PhIII success

Endpoints

Thu, 12/22/16 - 11:40 am

Safety issues with Roche drug good for Novo Nordisk

BioPharma Dive

Thu, 11/3/16 - 01:30 pm

Hey, wait a second. What about Roche’s PhIII hemophilia A drug?

Endpoints

Fri, 07/29/16 - 11:24 am

5 Reasons Roche Thinks It Can Outclass the Competition

Motley Fool

Fri, 11/13/15 - 04:23 pm

dry macular degeneration

Roche haemophilia drug wins fast-track FDA designation

Yahoo/Reuters

Fri, 09/4/15 - 10:29 am